WWC Securities, LLC, a leading middle-market investment banking firm, has changed its name to Outcome Capital, LLC, and it has added a life sciences and healthcare practice to complement its current practice in the IT services, software, and technology sectors. The Firm is opening a new office in Wellesley, MA where its life science and healthcare practice will be based.
“We believe the name change to Outcome Capital reflects our focus on the exceptional service we provide for our clients,” said Jonathan Wallace, Partner at Outcome Capital. “The team we are bringing on in Boston have demonstrated that they can deliver results across the life science industry and will make a great addition.”
Outcome Capital employs a unique market-driven and capital-efficient approach to identify key value and risk drivers and align strategic objectives with transaction opportunities. The firm’s multi-disciplinary team delivers differentiated transaction advisory services, and in the past 18 months, partners of Outcome Capital have closed over ten middle-market transactions including mergers, acquisitions, and the placement of private equity and debt.
Arnold Freedman and Dr. Oded Ben-Joseph, partners formerly of Boston Equity Advisors, will lead Outcome Capital’s healthcare practice. Recently, Dr. Ben-Joseph and Mr. Freedman were exclusive advisors to regenerative medicine company Histogenics Corporation.
